These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16254686)
1. Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networks. Jerez JM; Franco L; Alba E; Llombart-Cussac A; Lluch A; Ribelles N; Munárriz B; Martín M Breast Cancer Res Treat; 2005 Dec; 94(3):265-72. PubMed ID: 16254686 [TBL] [Abstract][Full Text] [Related]
2. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. De Laurentiis M; De Placido S; Bianco AR; Clark GM; Ravdin PM Clin Cancer Res; 1999 Dec; 5(12):4133-9. PubMed ID: 10632351 [TBL] [Abstract][Full Text] [Related]
3. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
5. Time-to-event analysis with artificial neural networks: an integrated analytical and rule-based study for breast cancer. Lisboa PJ; Etchells TA; Jarman IH; Hane Aung MS; Chabaud S; Bachelot T; Perol D; Gargi T; Bourdès V; Bonnevay S; Négrier S Neural Netw; 2008; 21(2-3):414-26. PubMed ID: 18304780 [TBL] [Abstract][Full Text] [Related]
6. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM; J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
8. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550 [TBL] [Abstract][Full Text] [Related]
9. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617 [TBL] [Abstract][Full Text] [Related]
10. Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches. Seker H; Odetayo MO; Petrovic D; Naguib RN; Bartoli C; Alasio L; Lakshmi MS; Sherbet GV Anticancer Res; 2002; 22(1A):433-8. PubMed ID: 12017328 [TBL] [Abstract][Full Text] [Related]
11. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence]. Fodor J Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868 [TBL] [Abstract][Full Text] [Related]
12. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study. Crocetti E; Mangone L; Lo Scocco G; Carli P Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092 [TBL] [Abstract][Full Text] [Related]
13. Predicting distant dissemination in patients with early breast cancer. Arriagada R; Rutqvist LE; Johansson H; Kramar A; Rotstein S Acta Oncol; 2008; 47(6):1113-21. PubMed ID: 18607866 [TBL] [Abstract][Full Text] [Related]
14. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM). Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507 [TBL] [Abstract][Full Text] [Related]
15. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
16. Artificial neural network for the joint modelling of discrete cause-specific hazards. Biganzoli EM; Boracchi P; Ambrogi F; Marubini E Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963 [TBL] [Abstract][Full Text] [Related]
17. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [TBL] [Abstract][Full Text] [Related]
18. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942 [TBL] [Abstract][Full Text] [Related]
19. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
20. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]